RXRX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

RXRXRecursion Pharmaceuticals, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

RXRXRecursion Pharmaceuticals, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only RXRX 14

NVDANvidiasupplier

GOOGLGoogle Cloudsupplier

TEMTempus AIsupplier

SNYSanoficustomer

10 more · RXRX chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

RXRXRecursion Pharmaceuticals, Inc.

3.85▼−4.46%

Mkt cap$2.2BRevenue$8MQ2 FY26Revenue$75MFY25

AMGNAmgen Inc

466.93▲+0.20%

Regular sessionNov 2 '26

Mkt cap$251.9BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

Compare

Regular sessionNov 2 '26

RXRXRecursion Pharmaceuticals, Inc.

AMGNAmgen Inc

3.85▼−4.46%

Price

466.93▲+0.20%

$2.2B

Mkt cap

$251.9B

Q2 FY26$8M

Revenue

$10.1BQ2 FY26

FY25$75M

Revenue

$36.8BFY25

RXRX3.85▼−4.46%vsAMGN466.93▲+0.20%Regular sessionNov 2 '26